Market access

Jonthan_Wilson
Jonathan Wilson, Spectrum president and head of GLOBALHealthPR’s North America hub

RxB_Logo_Tag_TM

 

There’s no better feeling when you run a client services agency than to identify a need and be able to deliver a solution. We get to do that today, with the introduction of Reimbursography, GLOBALHealthPR’s global strategic communications programme that leverages country-specific access insights to shape the value context for reimbursement success.

GLOBALHealthPR clients discover some of the world’s most innovative treatments for life-threatening conditions, saving and improving lives around the globe. They invest billions of dollars in the science and in the people who develop treatments for cancer, infectious and cardiovascular diseases, and more. Yet when their drugs make it through regulatory approvals, they face huge hurdles in global market access and reimbursement. A treatment’s value to the patient, to the community, to the healthcare system as a whole, is reduced to a discussion – usually an overwhelmingly contentious one – about the cost of the prescription.

But price is not really the issue here. It’s about recognition – by all decision makers – of the value that a new treatment brings to the market. To achieve that recognition, you need to build and tell a compelling and credible value story.

In our inaugural Reimbursography white paper, “Pharma Market Access Success: Shifting the Dialogue from Price to Value Through Strategic Communications,” we demonstrate how communications creates the right environment for value recognition.

Download the white paper
Download the white paper

Market Demand for a New Approach

At GLOBALHealthPR we see an opportunity to redefine market access communications, building the story early in the drug development process and sustaining it throughout the product lifecycle. Clients have increasingly turned to us for help with market access challenges. In the countries where we live and work, GLOBALHealthPR partners have seen restrictions attached to reimbursement agreements and reluctance of companies to even launch a product in some markets. Reimbursography reflects our collective capabilities to substantiate and communicate the value of an innovative treatment for funding, access, coverage and reimbursement in markets around the world.

 

What Makes GLOBALHealthPR Stand Out When it Comes to Market Access Communications

  • We are a connected global network that works effectively and efficiently in key geographies around the world. Check out our high-level market access and reimbursement insights for key markets in our Reimbursography guides.
  • Our partnership includes expertise in health communications, PhD scientists, best-in-class market access consultants and trusted counselors with in-country experience and relationship
  • We engage clients to conduct a value analysis and bring together company cross-functional leaders and key market access stakeholders for an open dialog about value, to ultimately arrive at a customised value communications playbook.

Download the white paper and get in touch with GLOBALHealthPR to learn how Reimbursography can help tell your product’s story to showcase its value to the marketplace.

Argentina Roadmap
A roadmap to health system efficiency?
Image: G. Novick presentation

In today’s post, Eugenia de la Fuente of GLOBALHealthPR Argentina partner Paradigma PEL Comunicación explains why Argentina needs a uniform health technology assessment process – and why the media should take notice of the issue.

 

[Read more…] about Dilemmas Over the Approval and Delivery of New Health Technologies in a Fragmented and Inefficient System

Today’s blog comes to us from our GLOBALHealthPR Australia partner, VIVA! Communications.

“By failing to prepare, you are preparing to fail.” –Benjamin Franklin 

4

Companies which succeed in the launch environment of 2018–2023 will take four essential steps now to ensure they are launch-ready for the future environment, according to the IMS Health report “Launch excellence IV: a new launch environment.”

At a special IMS Health one-day event in Sydney a couple weeks ago, consultant Frederic Lefebvre urged pharmaceutical companies to plan well in advance of  a product launch, citing eight-in-10 products show how they are set to perform within six months of launch, while those that do poorly during this period rarely recover.

[Read more…] about Four Essential Steps for Product Launch Success